Figure | Data structure | Type of test | Factors | Statistical data |
---|---|---|---|---|
1D | Normal distribution | Unpaired Student’s t test | Group (non-learner, learner) | t(13) = 2.71, p = 0.02, Cohen’s d =1.4 |
1E | Normal distribution | Unpaired Student’s t test | Group (non-learner, learner) | t(13) = 2.69, p = 0.02, Cohen’s d =1.4 |
2C | Normal distribution | Two-way ANOVA (Holm–Sidak post hoc analyses) | Group (non-learner, learner) × preassigned drug (vehicle, muscimol+baclofen) | Main effect of group (F(1,49) = 84.6, p < 0.0001, ηp² = 0.64); no main effect of preassigned drug condition (F(1,49) = 84.6, p = 0.92, ηp² < 0.001); and no group × preassigned drug interaction (F(1,49) < 0.001, p = 0.99, ηp² < 0.001) Vehicle: learner vs non-learner p < 0.0001 muscimol+baclofen: learner vs non-learner p < 0.0001 |
2D | Normal distribution | Two-way ANOVA | Group (non-learner, learner) × drug (vehicle, muscimol+baclofen) | Main effect of group (F(1,49) = 60.0, p < 0.0001, ηp² = 0.55); main effect of drug condition (F(1,49) = 10.9, p = 0.002, ηp² = 0.18); and group × drug interaction (F(1,49) = 12.14, p = 0.001, ηp² = 0.2) |
2E | Normal distribution | Two-way ANOVA | Group (non-learner, learner) × drug (vehicle, muscimol+baclofen) | Main effect of group (F(1,49) = 7.9, p = 0.007, ηp² = 0.14); no main effect of drug condition (F(1,49) = 0.26, p = 0.61, ηp² = 0.005); and no group × drug interaction (F(1,49) = 0.0005, p = 0.98, ηp² < 0.001) |
2F | Normal distribution | Two-way ANOVA | Group (non-learner, learner) × drug (vehicle, muscimol+baclofen) | Main effect of group (F(1,49) = 20.3, p < 0.0001, ηp² = 0.29); no main effect of drug condition (F(1,49) = 2.5, p = 0.12, ηp² = 0.048); and a group × drug interaction (F(1,49) = 4.25, p = 0.045, ηp² = 0.08) |
3C | Normal distribution | Two-way ANOVA (Holm–Sidak post hoc analyses) | Group (non-learner, learner) × preassigned drug (vehicle, daun02) | Main effect of group (F(1,37) = 38.7, p < 0.0001, ηp² = 0.51); no main effect of preassigned drug condition (F(1,37) = 0.09, p = 0.76, ηp² = 0.0.002); and no significant group × preassigned drug interaction (F(1,37) = 0.09, p = 0.76, ηp² = 0.002) vehicle: learner vs non-learner p = 0.0004 muscimol+baclofen: learner vs non-learner p < 0.0001 |
3D | Normal distribution | Two-way ANOVA (Holm–Sidak post hoc analyses) | Group (non-learner, learner) × drug (vehicle, daun02) | Main effect of group (F(1,37) = 24.1, p < 0.0001, ηp² = 0.39); no main effect of drug condition (F(1,37) = 0.46, p = 0.5, ηp² = 0.01); and a significant group × drug interaction (F(1,37) = 4.5, p = 0.042, ηp² = 0.11) non-learner: vehicle vs daun02 p = 0.37 learner: vehicle vs daun02 p = 0.048 |
3E | Normal distribution | Two-way ANOVA | Group (non-learner, learner) × drug (vehicle, daun02) | Main effect of group (F(1,37) = 8.4, p = 0.006, ηp² = 0.19); no main effect of drug condition (F(1,37) = 0.001, p = 0.97, ηp² < 0.0001); and no group × drug interaction (F(1,37) = 0.04, p = 0.83, ηp² = 0.001) |
3F | Normal distribution | Two-way ANOVA | Group (non-learner, learner) × drug (vehicle, daun02) | Main effect of group (F(1,37) = 7.9, p = 0.001, ηp² = 0.18); no main effect of drug condition (F(1,37) = 0.07, p = 0.79, ηp² = 0.002); and no group × drug interaction (F(1,37) = 0.9, p = 0.34, ηp² = 0.02) |
Detailed statistical analysis for each figure. Significant effects shown in bold.